Sonoma Pharmaceuticals Files 424B4 Prospectus
Ticker: SNOA · Form: 424B4 · Filed: Apr 27, 2026 · CIK: 0001367083
| Field | Detail |
|---|---|
| Company | Sonoma Pharmaceuticals, Inc. (SNOA) |
| Form Type | 424B4 |
| Filed Date | Apr 27, 2026 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: prospectus, offering, securities
TL;DR
Sonoma Pharma just dropped a 424B4 prospectus. Offering details coming soon.
AI Summary
Sonoma Pharmaceuticals, Inc. filed a 424B4 prospectus on April 27, 2026, detailing an offering of securities. The filing, with SEC Accession No. 0001683168-26-003212, provides information for potential investors regarding the terms and conditions of this offering. The company is based in Boulder, CO.
Why It Matters
This filing indicates Sonoma Pharmaceuticals is actively seeking capital through a public offering, which could impact its financial structure and future operations.
Risk Assessment
Risk Level: medium — A 424B4 filing signifies a new securities offering, which inherently carries market and execution risks for the company and investors.
Key Players & Entities
- Sonoma Pharmaceuticals, Inc. (company) — Filer of the prospectus
- 0001683168-26-003212 (other) — SEC Accession Number for the filing
- 2026-04-27 (date) — Filing date of the prospectus
- Boulder CO 80301 (location) — Company's mailing and business address
FAQ
What type of filing is this?
This is a 424B4 filing, which is a prospectus under Rule 424(b)(4).
When was this filing accepted by the SEC?
The filing was accepted on 2026-04-27 at 06:00:31.
What is the CIK number for Sonoma Pharmaceuticals, Inc.?
The CIK number for Sonoma Pharmaceuticals, Inc. is 0001367083.
Where is Sonoma Pharmaceuticals, Inc. located?
The company's mailing and business address is 5445 CONESTOGA COURT, SUITE 150, BOULDER CO 80301.
What is the SIC code for Sonoma Pharmaceuticals, Inc.?
The SIC code is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
Filing Details
This Form 424B4 (Form 424B4) was filed with the SEC on April 27, 2026 regarding Sonoma Pharmaceuticals, Inc. (SNOA).